[{"AccountsReceivableNetCurrent_0_Q1_USD":164801000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":3382000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":2487000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":26534000.0,"InsuranceSettlementsReceivableCurrent_0_Q1_USD":5130000.0,"IndefiniteLivedTradeNames_0_Q1_USD":5900000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":7214000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-34000.0,"EarlyRepaymentOfSeniorDebt_1_Q1_USD":0.0,"DirectOperatingCosts_1_Q1_USD":160461000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":11567000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":927000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":4757000.0,"LineOfCredit_0_Q1_USD":67648000.0,"RepaymentsOfLongTermLinesOfCredit_1_Q1_USD":110600000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":5988000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":37199000.0,"OtherLiabilitiesCurrent_0_Q1_USD":5743000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-78000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":736000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":-1300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":12599000.0,"OtherAssetsCurrent_0_Q1_USD":1726000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q1_USD":544000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-1846000.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":107274000.0,"IncomeTaxesReceivable_0_Q1_USD":300000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-729000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5205000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":6121000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4582000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1_Q1_USD":300000.0,"UnrecognizedTaxBenefits_0_Q1_USD":700000.0,"UnbilledContractsReceivable_0_Q1_USD":44700000.0,"StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_0_Q1_shares":510004.0,"ShortTermLeaseCost_1_Q1_USD":1845000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":210064000.0,"RestructuringCharges_1_Q1_USD":564000.0,"PaymentsToMinorityShareholders_1_Q1_USD":544000.0,"PaymentsForProceedsFromPreviousAcquisition_1_Q1_USD":0.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":100000.0,"OtherComprehensiveIncomeLossTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q1_USD":-78000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossBeforeTax_1_Q1_USD":-78000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0623,"OperatingLeaseRightOfUseAsset_0_Q1_USD":16263000.0,"OperatingLeasePayments_1_Q1_USD":1835000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":17992000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":4965000.0,"OperatingLeaseLiability_0_Q1_USD":22957000.0,"OperatingLeaseCost_1_Q1_USD":1523000.0,"NumberOfOperatingSegments_1_Q1_segment":3.0,"LiabilityForClaimsAndClaimsAdjustmentExpense_0_Q1_USD":27392000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":3577000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":3296000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":6300000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":31000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-78000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":42625000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":2596000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q1_USD":51095000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":35873000.0,"StockholdersEquity_0_Q1_USD":160757000.0,"Revenues_1_Q1_USD":210064000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-143864000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":11965000.0,"ProfitLoss_1_Q1_USD":-1768000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":962000.0,"NetIncomeLoss_1_Q1_USD":-2089000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":17162000.0,"InterestExpense_1_Q1_USD":867000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-962000.0,"LiabilitiesCurrent_0_Q1_USD":99002000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":386979000.0,"Liabilities_0_Q1_USD":225577000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3846000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":178000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.06,"CostsAndExpenses_1_Q1_USD":210818000.0,"CommonStockValue_0_Q1_USD":4000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":12599000.0,"AssetsCurrent_0_Q1_USD":190630000.0,"Assets_0_Q1_USD":386979000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":454920.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1318000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-4599000.0,"OperatingIncomeLoss_1_Q1_USD":-754000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":45881000.0,"ShareBasedCompensation_1_Q1_USD":927000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q1_USD":349000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-2167000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":539000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":305935000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":35873000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-635000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":18672000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":321000.0,"MinorityInterest_0_Q1_USD":645000.0,"Goodwill_0_Q1_USD":101066000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":6105000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":6028000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":5926000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":5289000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":11921000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":161402000.0,"PrepaidExpenseCurrent_0_Q1_USD":6374000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":31000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":42483000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":85108000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":0.0,"OtherNoncashExpense_1_Q1_USD":143000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-248000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":11066000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.112,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":7555000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":24078000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":35873000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-1590000.0,"VariableLeaseCost_1_Q1_USD":574000.0,"Ticker":"CCRN","CIK":"1141103","name":"CROSS COUNTRY HEALTHCARE INC","OfficialName":"Cross Country Healthcare Inc. Common Stock $0.0001 Par Value","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"808840854.0","Country":"United States","Sector":"Technology","Industry":"Diversified Commercial Services","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]